Panosian J O, Marinetti G V
Biochem Pharmacol. 1983 Jul 15;32(14):2243-7. doi: 10.1016/0006-2952(83)90233-2.
Human polymorphonuclear cell membranes contain alpha 2-adrenergic receptors which are measured by binding of the alpha 2-adrenergic antagonist [3H]yohimbine. The alpha 1-adrenergic antagonist [3H]prazosin showed no specific binding. High and low affinity sites were detected which had Kd values of 2.38 +/- 0.4 and 139 +/- 12 nM, respectively, and which bound maximally 4.82 +/- 0.9 and 81 +/- 9 fmoles of [3H]yohimbine/mg membrane protein. The high and low affinity sites were also detected by competition studies with phentolamine, epinephrine and norepinephrine and by dissociation kinetics of bound [3H]yohimbine. [3H]Yohimbine binding was stereospecifically inhibited by (-)- and (+)-epinephrine and norepinephrine. [3H]Yohimbine binding to intact cells showed about 500 high affinity sites per cell (Kd 0.5 nM) and approximately 4000 lower affinity sites per cell (Kd 3-4 nM). Yohimbine enhanced the (-)-norepinephrine stimulation of cAMP production in intact cells.
人类多形核细胞膜含有α2 - 肾上腺素能受体,可通过α2 - 肾上腺素能拮抗剂[3H]育亨宾的结合来测定。α1 - 肾上腺素能拮抗剂[3H]哌唑嗪未显示出特异性结合。检测到高亲和力和低亲和力位点,其解离常数(Kd)值分别为2.38±0.4和139±12 nM,每毫克膜蛋白分别最大结合4.82±0.9和81±9飞摩尔的[3H]育亨宾。通过与酚妥拉明、肾上腺素和去甲肾上腺素的竞争研究以及结合的[3H]育亨宾的解离动力学也检测到了高亲和力和低亲和力位点。[3H]育亨宾的结合被( - ) - 和( + ) - 肾上腺素和去甲肾上腺素立体特异性抑制。[3H]育亨宾与完整细胞的结合显示每个细胞约有500个高亲和力位点(Kd 0.5 nM)和约4000个低亲和力位点(Kd 3 - 4 nM)。育亨宾增强了完整细胞中( - ) - 去甲肾上腺素对环磷酸腺苷(cAMP)产生的刺激作用。